Baricitinib and low‐dose prednisone for very severe alopecia areata: A retrospective case series

Key Points

• The aim is to evaluate the effectiveness of baricitinib combined with low-dose prednisone for treating very severe alopecia areata.
• Conducted a retrospective analysis of cases
• Administered baricitinib and low-dose prednisone
• Evaluated patient outcomes related to hair regrowth
• Significant improvement in hair regrowth observed in many cases
• Combined therapy was generally well-tolerated
• Responses varied among individuals with different severity levels